319 related articles for article (PubMed ID: 19200820)
1. Genome-based approaches to develop vaccines against bacterial pathogens.
Serruto D; Serino L; Masignani V; Pizza M
Vaccine; 2009 May; 27(25-26):3245-50. PubMed ID: 19200820
[TBL] [Abstract][Full Text] [Related]
2. Genome-based vaccine development: a short cut for the future.
Moriel DG; Scarselli M; Serino L; Mora M; Rappuoli R; Masignani V
Hum Vaccin; 2008; 4(3):184-8. PubMed ID: 20686357
[TBL] [Abstract][Full Text] [Related]
3. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens.
Serruto D; Adu-Bobie J; Capecchi B; Rappuoli R; Pizza M; Masignani V
J Biotechnol; 2004 Sep; 113(1-3):15-32. PubMed ID: 15380644
[TBL] [Abstract][Full Text] [Related]
4. Post-genomic vaccine development.
Serruto D; Rappuoli R
FEBS Lett; 2006 May; 580(12):2985-92. PubMed ID: 16716781
[TBL] [Abstract][Full Text] [Related]
5. Identification of new meningococcal serogroup B surface antigens through a systematic analysis of neisserial genomes.
Pajon R; Yero D; Niebla O; Climent Y; Sardiñas G; García D; Perera Y; Llanes A; Delgado M; Cobas K; Caballero E; Taylor S; Brookes C; Gorringe A
Vaccine; 2009 Dec; 28(2):532-41. PubMed ID: 19837092
[TBL] [Abstract][Full Text] [Related]
6. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach.
Mora M; Donati C; Medini D; Covacci A; Rappuoli R
Curr Opin Microbiol; 2006 Oct; 9(5):532-6. PubMed ID: 16890009
[TBL] [Abstract][Full Text] [Related]
7. Genome-based vaccine development: a short cut for the future.
Moriel DG; Scarselli M; Serino L; Mora M; Rappuoli R; Masignani V
Adv Exp Med Biol; 2009; 655():81-9. PubMed ID: 20047037
[TBL] [Abstract][Full Text] [Related]
8. Antigen identification starting from the genome: a "Reverse Vaccinology" approach applied to MenB.
Palumbo E; Fiaschi L; Brunelli B; Marchi S; Savino S; Pizza M
Methods Mol Biol; 2012; 799():361-403. PubMed ID: 21993656
[TBL] [Abstract][Full Text] [Related]
9. Developing vaccines in the era of genomics: a decade of reverse vaccinology.
Seib KL; Zhao X; Rappuoli R
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():109-16. PubMed ID: 22882709
[TBL] [Abstract][Full Text] [Related]
10. Vaccines in the era of genomics: the pneumococcal challenge.
Barocchi MA; Censini S; Rappuoli R
Vaccine; 2007 Apr; 25(16):2963-73. PubMed ID: 17324490
[TBL] [Abstract][Full Text] [Related]
11. Reverse vaccinology and vaccines for serogroup B Neisseria meningitidis.
Kelly DF; Rappuoli R
Adv Exp Med Biol; 2005; 568():217-23. PubMed ID: 16107075
[TBL] [Abstract][Full Text] [Related]
12. Quadrivalent meningococcal conjugate vaccines.
Pace D; Pollard AJ; Messonier NE
Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
[TBL] [Abstract][Full Text] [Related]
13. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
[TBL] [Abstract][Full Text] [Related]
14. Meningococcal disease: a review on available vaccines and vaccines in development.
Bröker M; Fantoni S
Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
[TBL] [Abstract][Full Text] [Related]
15. Towards a universal group B Streptococcus vaccine using multistrain genome analysis.
Tettelin H; Medini D; Donati C; Masignani V
Expert Rev Vaccines; 2006 Oct; 5(5):687-94. PubMed ID: 17181441
[TBL] [Abstract][Full Text] [Related]
16. Universal protein vaccines against Neisseria meningitidis serogroup B, Streptococcus pneumoniae and influenza.
Principi N; Esposito S
Hum Vaccin; 2011 Sep; 7(9):905-12. PubMed ID: 21865879
[TBL] [Abstract][Full Text] [Related]
17. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
[TBL] [Abstract][Full Text] [Related]
18. Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus.
Bambini S; Muzzi A; Olcen P; Rappuoli R; Pizza M; Comanducci M
Vaccine; 2009 May; 27(21):2794-803. PubMed ID: 19428890
[TBL] [Abstract][Full Text] [Related]
19. Genome-based bacterial vaccines: current state and future outlook.
Schubert-Unkmeir A; Christodoulides M
BioDrugs; 2013 Oct; 27(5):419-30. PubMed ID: 23588477
[TBL] [Abstract][Full Text] [Related]
20. Developing antibacterial vaccines in genomics and proteomics era.
Kaushik DK; Sehgal D
Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
